VICTORIA, British Columbia, March 12, 2026 (GLOBE NEWSWIRE)-- Eupraxia Pharmaceuticals Inc. ("Eupraxia” or the "Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ...

Earnings call Health Catalyst reported Q4 2025 revenue of $74.7M (down YoY), with full-year revenue up 1% to $311.1M and Adjusted EBITDA up 59% to $41.4M. Despite strong cost control and margin gains, ...

Futures trading involves a substantial risk of loss and may not be suitable for all investors. Therefore, carefully consider whether such trading is suitable for you in light of your financial ...

BLANTYRE-(MaraviPost)-Malawi’s national football team, the Flames Head coach Kalisto Pasuwa has appointed Fischer Anong’a Kondowe as the team’s Fitness Coach, replacing Peter Mgangira, who remains ...

The theme for the day is Innovation at Scale, Value that Endures. We spent a lot of time thinking about those 6 words over the last few months. And I hope by the end of the day, they resonate with you ...

TEHRAN-(MaraviPost)-Iran has announced that it will not participate in the upcoming 2026 FIFA World Cup, citing escalating political and security tensions with the United States. The announcement was ...

Earnings call McEwen Mining delivered a strong Q4 and full-year 2025, with gross profit more than doubling sequentially and a swing to net income of $34.4M for the year, up from a $43.7M loss in 2024.

Following the Iranian missile strikes, this analysis identifies six strategic companies that could be well-positioned to benefit from the resulting surge in defense spending, rare earth supply chain ...

H2O America (NASDAQ:HTO) Q4 2025 Earnings Call Transcript February 26, 2026 Operator: Good day, and thank you for standing by. Welcome to the H2O America's Fourth Quarter Financial Results Call.

Artificial intelligence continues to make waves in markets, spurring new investments and concerns each week. Nvidia (NVDA) is drumming up anticipation for its flagship developer conference next week, ...

Full year 2025 total revenues increased by 27% to US$376.1 million, driven by continued growth of RUCONEST® and rising demand for Joenja® (leniolisib) Fourth quarter 2025 total revenues increased by ...

McEwen Inc. (NYSE/TSX: MUX) today announced its fourth quarter (Q4) and full year results for the period ended December 31, 2025, along with an update on its ...